Ubiquilin -4 acts as a tumor suppressor during the progression of gastric cancer by inducing cell cycle arrest and senescence via the extracellular signal-regulated kinases (ERK) signaling pathway [13, 14]. The gene discussed is UBQLN4; the disease is neoplasm.